Yes mate, the likes of BOT are very close to a drug being...

Yes mate, the likes of BOT are very close to a drug being approved by the FDA, any spec biotech on any exchange has been belted. Compass and ATAI at multi year lows like we are. These companies are 12-18 from potential FDA approvals.
I am not blaming ASX or anyone for IHL’s price, BUT as we start to roll in to genuine news, I think there is potential for far bigger rewards on the NDQ. Also not blaming the board because similar companies have been treated the same.

Time will tell, but for those of us still here, I am looking fwd to the next period. Last 18 months has been terrible, the 18 before that we were all rock stars.